Literature DB >> 11442302

Structural neuroimaging of Alzheimer's disease and other dementias.

P H Scheltens1.   

Abstract

This paper reviews the use of imaging techniques to aid in the clinical diagnosis of dementia. Two approaches are distinguished. One is the exclusionary approach in which imaging is used to rule out diseases that would mimic or cause dementia; based on the literature, this approach yields very little, if any, information that was not identified clinically. The more positive approach uses imaging as a diagnostic tool to identify changes specific for causes of dementia; any assessment of medial temporal lobe atrophy on Magnetic Resonance Imaging (MRI) will result in a reasonably high positive likelihood ratio distinguishing AD patients from non-demented individuals, but fails to distinguish AD patients from patients with other dementias. For a diagnosis of vascular dementia imaging is necessary, although not all vascular changes fulfill requirements of being relevant to dementia. Potentially of more importance, given the higher prevalence of AD, is the identification of concomitant vascular changes in AD that may be amenable to therapy, and may be used to identify subgroups. Structural and functional MRI techniques have great potential in identifying patients at risk for AD, which will allow for a very early treatment with drugs that slow or even halt progression.

Entities:  

Mesh:

Year:  2001        PMID: 11442302     DOI: 10.1007/BF03351478

Source DB:  PubMed          Journal:  Aging (Milano)        ISSN: 0394-9532


  7 in total

1.  Mild Alzheimer's disease: a "position paper".

Authors:  J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

2.  Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging.

Authors:  Shawn M Marks; Samuel N Lockhart; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2017-02-17       Impact factor: 6.167

3.  Visual assessment of posterior atrophy development of a MRI rating scale.

Authors:  Esther L G E Koedam; Manja Lehmann; Wiesje M van der Flier; Philip Scheltens; Yolande A L Pijnenburg; Nick Fox; Frederik Barkhof; Mike P Wattjes
Journal:  Eur Radiol       Date:  2011-07-31       Impact factor: 5.315

4.  Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia.

Authors:  Maria Lage Barca; Dag Alnæs; Knut Engedal; Karin Persson; Rannveig Sakshaug Eldholm; Nikias Siafarikas; Ina Selseth Almdahl; Maria Stylianou-Korsnes; Ingvild Saltvedt; Geir Selbæk; Lars T Westlye
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2022-06-23

5.  Integrated (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging ((18)F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay.

Authors:  Amarnath Jena; Pushpendra Nath Renjen; Sangeeta Taneja; Aashish Gambhir; Pradeep Negi
Journal:  Indian J Radiol Imaging       Date:  2015 Oct-Dec

6.  Identifying brain changes related to cognitive aging using VBM and visual rating scales.

Authors:  Valentina Pergher; Philippe Demaerel; Olivier Soenen; Carina Saarela; Jos Tournoy; Birgitte Schoenmakers; Mira Karrasch; Marc M Van Hulle
Journal:  Neuroimage Clin       Date:  2019-02-05       Impact factor: 4.881

7.  Cerebrospinal fluid volumetric MRI mapping as a simple measurement for evaluating brain atrophy.

Authors:  J B De Vis; J J Zwanenburg; L A van der Kleij; J M Spijkerman; G J Biessels; J Hendrikse; E T Petersen
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.